关注
Emilie Roger
Emilie Roger
Laboratoire MINT (Inserm U1066 CNRS 6021)
在 univ-angers.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery
E Roger, F Lagarce, E Garcion, JP Benoit
Nanomedicine 5 (2), 287-306, 2010
3402010
Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis
E Roger, F Lagarce, E Garcion, JP Benoit
Journal of controlled release 140 (2), 174-181, 2009
2812009
CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
SK Swaminathan, E Roger, U Toti, L Niu, JR Ohlfest, J Panyam
Journal of Controlled Release 171 (3), 280-287, 2013
2072013
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting
NT Huynh, E Roger, N Lautram, JP Benoît, C Passirani
Nanomedicine 5 (9), 1415-1433, 2010
2012010
Folic acid functionalized nanoparticles for enhanced oral drug delivery
E Roger, S Kalscheuer, A Kirtane, BR Guru, AE Grill, J Whittum-Hudson, ...
Molecular pharmaceutics 9 (7), 2103-2110, 2012
1922012
Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets
AS Klymchenko, E Roger, N Anton, H Anton, I Shulov, J Vermot, Y Mely, ...
RSC advances 2 (31), 11876-11886, 2012
1702012
On the benefits of rubbing salt in the cut: Self-healing of saloplastic PAA/PAH compact polyelectrolyte complexes
A Reisch, E Roger, T Phoeung, C Antheaume, C Orthlieb, F Boulmedais, ...
Adv. Mater 26 (16), 2547-2551, 2014
1422014
Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration
E Roger, F Lagarce, JP Benoit
European journal of pharmaceutics and biopharmaceutics 79 (1), 181-188, 2011
1402011
The gastrointestinal stability of lipid nanocapsules
E Roger, F Lagarce, JP Benoit
International journal of pharmaceutics 379 (2), 260-265, 2009
1242009
Models for drug absorption from the small intestine: where are we and where are we going?
PA Billat, E Roger, S Faure, F Lagarce
Drug discovery today 22 (5), 761-775, 2017
1222017
Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel
J Hureaux, F Lagarce, F Gagnadoux, L Vecellio, A Clavreul, E Roger, ...
European journal of pharmaceutics and biopharmaceutics 73 (2), 239-246, 2009
1202009
How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?
H Malhaire, JC Gimel, E Roger, JP Benoît, F Lagarce
Advanced drug delivery reviews 106, 320-336, 2016
992016
Compact saloplastic poly (acrylic acid)/poly (allylamine) complexes: Kinetic control over composition, microstructure, and mechanical properties
A Reisch, P Tirado, E Roger, F Boulmedais, D Collin, JC Voegel, B Frisch, ...
Advanced Functional Materials 23 (6), 673-682, 2013
772013
Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells
E Roger, F Lagarce, E Garcion, JP Benoit
European Journal of Pharmaceutical Sciences 40 (5), 422-429, 2010
722010
Spontaneous nano-emulsification: Process optimization and modeling for the prediction of the nanoemulsion’s size and polydispersity
G Lefebvre, J Riou, G Bastiat, E Roger, K Frombach, JC Gimel, P Saulnier, ...
International journal of pharmaceutics 534 (1-2), 220-228, 2017
672017
Advances in treatment formulations for acute myeloid leukemia
T Briot, E Roger, S Thépot, F Lagarce
Drug discovery today 23 (12), 1936-1949, 2018
532018
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
A Clavreul, E Roger, M Pourbaghi-Masouleh, L Lemaire, C Tétaud, ...
Drug Delivery 25 (1), 1756-1765, 2018
482018
Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model
E Roger, JC Gimel, C Bensley, AS Klymchenko, JP Benoit
Journal of controlled release 253, 11-18, 2017
462017
Alginate/chitosan compact polyelectrolyte complexes: a cell and bacterial repellent material
T Phoeung, MV Spanedda, E Roger, B Heurtault, S Fournel, A Reisch, ...
Chemistry of Materials 29 (24), 10418-10425, 2017
332017
Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
A Clavreul, M Pourbaghi-Masouleh, E Roger, N Lautram, ...
Journal of Experimental & Clinical Cancer Research 36, 1-11, 2017
312017
系统目前无法执行此操作,请稍后再试。
文章 1–20